I am a PhD candidate in Biomedical Engineering at New York University, co-mentored by Dr. Kelly Ruggles and Dr. Jeffrey Berger at the NYU Tandon School of Engineering and NYU Langone Health. My research sits at the intersection of multi-omic computational biology and cardiovascular medicine, with a focus on discovering translational biomarkers and molecular disease subtypes in high-risk patient populations.
I use blood-based multi-omic profiling to identify and explain residual cardiovascular risk, the events that still occur in patients receiving the best available care. In the ISCHEMIA trials biorepository, I integrate genomics, transcriptomics, methylomics, and proteomics to define molecular subtypes of chronic coronary disease with divergent outcomes. I also develop platelet-based RNA and protein scores (PRESS, TIPS, PROSPER) that flag patients whose risk is driven by platelet reactivity. My work includes 30+ publications, 10+ as first author, and two U.S. provisional patents.
Prior to my PhD, I spent four years working with Dr. Jonathan Lindner at the Knight Cardiovascular Institute at OHSU investigating therapeutic and diagnostic ultrasound, characterizing shear-dependent vasoactive pathways and VWF-mediated thromboinflammatory mechanisms in peripheral artery disease and aortic stenosis.